Articles
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study
European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (EAS FHSC)
Journal:
Lancet Diabetes Endocrinol
First published: October 3, 2024 DOI: 10.1016/S2213-8587(24)00221-3